"We're particularly excited about Dototate, a peptide that binds to somatostatin receptors," said Jonathan McConathy, MD, PhD, Director of the Division of Molecular Imaging and Therapeutics at UAB.
New research, new tools bring new hope when it comes to preventing and treating breast cancer.
You may not be getting all you can out of your browsing experience
and may be open to security risks!
Consider upgrading to the latest version of your browser or choose on below: